Exosome-Associated Gene Signature for Predicting the Prognosis of Ovarian Cancer Patients

Figure 8

Predictive role of risk scores for different responses to immunotherapy strategies. (a) Without immunotherapy, high-risk scores resulted in poor prognosis compared with low-risk scores (). (b) If only anti-PD1 immunotherapy was conducted, the group with higher risk scores had a poorer therapeutic effect than the group with lower risk scores (). (c) If only anti-CTLA4 immunotherapy was used, the high-risk group had a worse prognosis compared with the low-risk group (). (d) When anti-PD1 and anti-CTLA4 immunotherapies were used simultaneously, there was a significantly better prognosis in the low-risk group than in the high-risk group ().

(a)

(b)

(c)

(d)